Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2–containing low-molecular-weight heparin (Fragmin)/protamine nanoparticles
-
Published:2015-06
Issue:2
Volume:196
Page:247-257
-
ISSN:0022-4804
-
Container-title:Journal of Surgical Research
-
language:en
-
Short-container-title:Journal of Surgical Research
Author:
Takikawa MakotoORCID,
Nakamura Shingo,
Ishihara Masayuki,
Takabayashi Yuki,
Fujita Masanori,
Hattori Hidemi,
Kushibiki Toshihiro,
Ishihara Miya
Reference26 articles.
1. Heparan sulfate: a piece of information;Salmivirta;FASEB J,1996
2. Structure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activities;Ishihara;Trends Glycosci Glycotechnol,1998
3. Novel experimental and clinical therapeutic uses of low-molecular-weight heparin/protamine microparticles;Kishimoto;Pharmaceutics,2012
4. Heparin and low-molecular heparin, mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety;Hirsh;Chest,2001
5. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin®) at the site of activation of the coagulation system in man;Wolzt;Thromb Haemost,1995
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献